Page last updated: 2024-09-03

3-iodo-alpha-methyltyrosine and Head and Neck Neoplasms

3-iodo-alpha-methyltyrosine has been researched along with Head and Neck Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bossuyt, A; Deron, P; Dierickx, LO; Everaert, H; Lahoutte, T; Voordeckers, M1
Amthauer, H; Bischoff, A; Denecke, T; Felix, R; Kuczer, D; Michel, R; Plotkin, M; Ruf, J; Schlenger, L; Wurm, R; Wust, P1
Bossuyt, A; Caveliers, V; Deron, P; Dierickx, LO; Everaert, H; Lahoutte, T; Vanhove, C1

Trials

3 trial(s) available for 3-iodo-alpha-methyltyrosine and Head and Neck Neoplasms

ArticleYear
Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Nuclear medicine communications, 2003, Volume: 24, Issue:6

    Topics: Aged; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2003
Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
    Onkologie, 2006, Volume: 29, Issue:4

    Topics: Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Methyltyrosines; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2006
Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2001